Literature DB >> 17766182

H is for helper: granzyme H helps granzyme B kill adenovirus-infected cells.

Nigel J Waterhouse1, Joseph A Trapani.   

Abstract

It is commonly held that the various granzymes (lethal proteases produced by cytotoxic lymphocytes) utilize their different substrate preferences to bring about various forms of target cell death. Although a considerable body of evidence supports this view, it has now become clear that human granzyme H could have evolved a proteolytic specificity that both interferes directly with adenovirus replication and prevents the virus from blocking the potent pro-apoptotic activity of granzyme B.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766182     DOI: 10.1016/j.it.2007.08.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  4 in total

1.  Regulation of perforin lysis: implications for protein disulfide isomerase proteins.

Authors:  David L Tamang; Bryce N Alves; Viki Elliott; Doug Redelman; Renu Wadhwa; Stephanie A Fraser; Dorothy Hudig
Journal:  Cell Immunol       Date:  2009-01-14       Impact factor: 4.868

2.  Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans.

Authors:  William E Yang; Sunil Suchindran; Bradly P Nicholson; Micah T McClain; Thomas Burke; Geoffrey S Ginsburg; Clayton D Harro; Subhra Chakraborty; David A Sack; Christopher W Woods; Ephraim L Tsalik
Journal:  J Infect Dis       Date:  2016-01-18       Impact factor: 5.226

3.  Granzyme B Is an Essential Mediator in CD8+ T Cell Killing of Theileria parva-Infected Cells.

Authors:  Jie Yang; Alan Pemberton; W Ivan Morrison; Tim Connelley
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

Review 4.  Natural Killer Cells: Angels and Devils for Immunotherapy.

Authors:  Beatriz Martín-Antonio; Guillermo Suñe; Lorena Perez-Amill; Maria Castella; Alvaro Urbano-Ispizua
Journal:  Int J Mol Sci       Date:  2017-08-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.